Home
Clinical Resources Search
PQI: Trilaciclib (Cosela) Management

Trilaciclib (Cosela) Management

Download PQI pdf

Last Updated: May 28, 2024

By: Autumn Alvarez, PharmD, BCPS

About this PQI

The purpose of this PQI is to describe the indication, pharmacology and dosing of trilaciclib.

More About This PQI

PQI in Action Articles:

trilaciclib_cosela_management pdf

How to Use a Positive Quality Intervention (PQI)

Essentially, it’s a tool to improve patient care by sharing best practices in oncology care.

Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.

Frequently Searched

Supported by

Trilaciclib (Cosela) Management

About this PQI

More About This PQI

PQI in Action Articles:

How to Use a Positive Quality Intervention (PQI)

Find Similar Resources

PQI: Encorafenib (Braftovi) + Cetuximab (Erbitux) + FOLFIRI for BRAF V600E-Positive Metastatic Colorectal Cancer

PQI: Reflex Biomarker Testing in Metastatic Colorectal Cancer: Implementing BRAF and MSI Assessment

PQI: Amivantamab and Hyaluronidase plus Lazertinib Patient Management

PQI: Belantamab Mafodotin (Blenrep) for the Management of Multiple Myeloma

PQI in Action: Revumenib (Revuforj) for the Management of Acute Leukemia

PQI in Action: Capivasertib (Truqap) Patient Management

PQI in Action: Sutimlimab-jome (Enjaymo) for the Management of Hemolysis in Cold Agglutinin Disease (CAD)

PQI in Action: Darolutamide (Nubeqa)

S10 E14: Optimizing Access Through OOLD

S10 E12: Inside GU Oncology with Uromigos Co-Host

S10 E15: From Student to Fellow to Leader: Exploring Pharmacy Fellowships

S10 E13: Oncology Unfiltered: AI and the Future of Cancer Care

Toolkit: Simplify CLL Tracking in Oncology Practices

Toolkit: Optimize CLL Care in Epic

Treatment Support Kit: Elranatamab

Treatment Support Kit: Bi-Specific

Treatment Support Kit: Mirdametinib

Treatment Support Kit: Abemaciclib

Video: Akynzeo® (Ready-to-Use Vial): A Step-by-Step Video Guide

Video: Ibrutinib-Related Cardiac Toxicities: Management & Dose Modifications

Video: Neratinib for Extended Adjuvent Treatment of Adult Patients with Early-Stage HER2-Positive Breast Cancer (MIP)

Video: BRUKINSA® (Zanubrutinib) for Treatment of Relapsed or Refractory Marginal Zone Lymphoma

Bevacizumab, Carboplatin, and Paclitaxel

Pembrolizumab, Carboplatin and Paclitaxel

Zenocutuzumab

Amivantamab and Hyaluronidase

PQI in Action: Trilaciclib (Cosela) Management

Doxorubicin

Irinotecan

Atezolizumab and Lurbinectedin

Pembrolizumab and Berahyaluronidase Alfa

Trilaciclib

PQI in Action: Trilaciclib (Cosela) Management

Filgrastim

Pegfilgrastim

Pamidronate

How to Categorize Cancer Drug Therapy

Trilaciclib

PQI in Action: Trilaciclib (Cosela) Management

PQI in Action: Revumenib (Revuforj) for the Management of Acute Leukemia

Acalabrutinib, Venetoclax, and Obinutuzumab

Afamitresgene Autoleucel

Step Edit Series

Related Content

PQI in Action: Trilaciclib (Cosela) Management